Evan  Cantor, MD, JD

Evan Cantor, MD, JD

Hometown: New York City, NY
Undergraduate: Cornell University, Ithaca, NY
JD: Albany Law School, Albany, NY
MD: Medical School of International Health, Beer Sheva, Israel
Residency: NYU-Winthrop Hospital, Mineola, NY
Fellowship: University of Michigan, Ann Arbor, MI
Evan Cantor, MD, JD, joined us in 2021 for a one year focused fellowship in neuro-oncology after completing a three year pediatric hematology/oncology fellowship in Michigan. His goals for the year include learning more about early phase trial design and implementation, as well as clinical neuro-oncology, in order to take care of his current and future patients as best as possible. His research interests include utilizing cell-free tumor DNA for liquid biopsy of tumors, as well as characterization of the RNA fusion landscape in high grade gliomas.

Irem  Eldem, MD

Irem Eldem, MD


Hometown: Ankara, Turkey
MD: Hacettepe University School of Medicine, 2011
Residency: Ankara University School of Medicine (2016) and Texas Tech University Health Sciences Center, Lubbock, TX (2020)
Irem Eldem, MD, started fellowship in 2020. She is currently working in the DiPaola lab, where her research focuses on the role of tissue factor pathway inhibitor (TFPI) in the early phases of the procoagulant response and endotoxin-induced coagulation. The benefits of pharmacological target of TFPI will be helpful for bleeding and thrombosis disorders such as hemophilia and East Texas syndrome. Another potential benefit will be to understand the inflammation related coagulopathy via TFPI such as in COVID patients.

Sobya  Hashmi, MD

Sobya Hashmi, MD

Hometown: Los Angeles, CA
MD: Dow University of Health Sciences
Residency: Abbasi Shaheed Hospital, 2018
Sobya Hashmi, MD, started fellowship in 2021. She is interested in both basic science and clinical research. She previously worked as a Clinical Research Associate in California, which exposed her to clinical trial design and engendered a strong interest in learning about trials related to hematologic malignancies. Hashmi is particularly interested in acute leukemias. Outside of medicine, she enjoys biking and traveling with her family. She has enjoyed exploring the beautiful city of St. Louis with its great outdoor opportunities and family fun activities. She is excited to learn from the esteemed clinical and academic faculty here and be a part of the WashU family!

Megha  Malhotra, MD

Megha Malhotra, MD

Hometown: Halifax, Nova Scotia, Canada
Undergraduate: BSc Double Major in Neuroscience and Theatre Studies, Dalhousie University, Canada
MBBS: Kasturba Medical College, Manipal, Karnataka, India, 2015
Residency: Southern Illinois University School of Medicine, Springfield, IL, 2019
Megha Malhotra, MD, started fellowship in 2019. Her interests are in hematopoietic stem cell transplantation and novel therapies (cellular and targeted) for pediatric high-risk malignancies, particularly in demonstrating their application via new clinical trials. Under her primary mentor, Sima Bhatt, MD, she is developing an allogeneic HSCT trial using an advanced ex vivo graft modification technique for haploidentical products to maintain adequate engraftment and the graft versus leukemia effect, while minimizing adverse effects such as graft versus host and relapse. Other projects include a Phase 2 trial utilizing CD22 targeted immunotherapy pre-emptively for high-risk B-ALL patients who remain NGS positive following stem cell transplant. Malhotra's review of contemporary approaches for HSCT in CGD patients was recently published in Pediatric Medicine. Her other passions include advocating for diversity and inclusion within the healthcare system (both for providers and patients) and playing hide-and-seek with her recently adopted beagle, Ginger.

Shilpa  Rampey Venkata  Naga, MD

Shilpa Rampey Venkata Naga, MD


Hometown: Bangalore, India
MD: M.S. Ramaiah Medical College, Bangalore, India, 2016
Residency: Rutgers New Jersey Medical School, NJ, 2020
Shilpa Rampey Venkata Naga, MD, started her fellowship in 2020. She is currently working with Melanie Fields, MD, to design a web-based tool to augment medical education for parents of children newly diagnosed with cancer.

Dalia  Selim, MD, PhD

Dalia Selim, MD, PhD

Hometown: Cairo, Egypt
MD: Ain Shams University, School of Medicine, Egypt, 2002
Residency: Ain Shams University, School of Medicine, 2005
PhD: Ain Shams University, School of Medicine, 2009
Hematology and Stem Cell Transplant Fellowship, and BMT service, Nasser Institute, Egypt, 2014
Dalia Selim, MD, PhD, started her fellowship in 2021. She previously completed a pediatric hematology/oncology fellowship at Ain Shams and served as a pediatric bone marrow transplant fellow at Nasser Institute for Research and Treatment. She then worked as a visiting clinical fellow in bone marrow transplant at Seattle Children’s Hospital from 2015-2016, where she studied NRPM1 mutations and outcomes in acute myeloblastic leukemia.

Meghana  Srinivas, MD

Meghana Srinivas, MD


Hometown: Mysore, India
MD: Raichur Institute of Medical Sciences, India, 2016
Residency: Rutgers New Jersey Medical School, NJ, 2020
Meghana Srinivas, MD, started fellowship in 2020. She is interested in improving the lives of children with high-risk leukemias through direct clinical work as well as clinical research. She is especially interested in the long-term sequelae of leukemia and its treatment for patients and families, and is working with Bryan Sisk, MD, on a project employing semi-structured interviews and Dephi consensus processes to identify targets for communication interventions. In her free time, Srinivas enjoys traveling, hiking, cooking. She is an avid reader and enjoys painting.